Guest Contributor

Health firms dominate biotech sector as increases in R&D expenditures accelerate

Guest Contributor
June 30, 2000

Biotech R&D spending in 1997 by Canada's biotechnology sector skyrocketed by 28% above the previous year, with $446 million in outlays by firms that spent at least $1 million on R&D. Moreover, the total R&D performed by firms conducting biotech R&D reached $904 million in the same year, representing 5.

... Please become a Member or login to read the rest of this article ...


Other stories mentioning these organizations, people and topics

Other News

NRC's Manufacturing Technologies Group makes pitch for increase in base funding with new five-year strategic plan

Tech transfer focus of six awards at this year's FPTT conference

Coordination considered key as proposed international S&T initiatives go to Cabinet for consideration in next Budget

CIHR now official as new governing council unveiled under leadership of Alan Bernstein






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 0 free articles remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.